Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,012

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,012 results for “neurological”

Learn how ShareScore rates datasets ↗
geo12/100

Alternative splicing at the last coding exon of Cav2.1 regulates the interaction with Cav4 and plays an essential role in preventing a complex neurological disease in mice

GEO Series GSE85023. Mus musculus. 18 samples. Type: Expression profiling by array.

openGEO-OpenAug 2017View details →
geo12/100

Central nervous system-compartmentalized pathogenic B cells promote neurological inflammation relapses

GEO Series GSE253740. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2025View details →
geo12/100

Inactivation of DET1 causes neurological defects and lethality in mice and humans I

GEO Series GSE271764. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2025View details →
zenodo12/100

MGMT promoter gene methylation and Neurological Scale Improvement in Glioma: a cohort study

<p><strong>Abstract</strong></p> <p><strong>Background:</strong> Glioma as one of the most common primary brain tumors remains to convey a dismal prognosis despite of aggressive treatment. Several biomarkers have been studied in hope to yield diagnostic accuracy and improve patient management.&nbsp; Besides of survival, functional and neurological disability is one of the concerns that have no lesser importance. In 2017, a disease-specific assessment tool &ndash; the NANO scale &ndash; was developed to measure neurologic function in neuro-oncology cases. We sought to determine biomarkers that might be associated with neurological scale improvement in glioma patients.</p> <p>&nbsp;</p> <p>&nbsp;</p> <p><strong>Methods:</strong> Glioma grade II-IV were recruited from 3 major hospitals in Jakarta-Tangerang. IDH mutation and MGMT promoter gene methylation were tested, as well as patients&rsquo; neurological scale before surgery and 3 months after. Improvement in neurological scale (NANO scale) is considered positive if there was a decrement of &ge;1 of the scale.</p> <p>&nbsp;</p> <p><strong>Results:</strong> There were 54 patients included in the study. Mean age was 43.63 (14.723) years old, and 61.1% were male. As much as 16 (29.6%) carried a mutation in codon 132 of the IDH1 gene, and 33 (61.1%) were MGMT methylated. Median NANO Scale before and 3 months after surgery was 4 (0-12) and 3(0-12). Improvement in neurological scale was found in 44 (81.5%) of the patients. Among patients with MGMT promoter gene methylation, 90.9% shows improvement in neurological scale (p=0.035; OR=5; 95%CI 1.122-22.272).</p> <p>&nbsp;</p> <p><strong>Conclusions:</strong> Glioma with MGMT promoter gene methylation are more likely to show neurological scale improvement 3 months after surgery.</p>

restrictedJan 2021View details →
zenodo12/100

Neurological complications in patient treated with checkpoint inhibitors

<p>Neurological immune-related adverse events (nirAEs) are rare toxicities of immune-checkpoint inhibitors (ICI). With the increase of ICI oncological indications, their incidence is growing. Their recognition and management remain nevertheless challenging.</p> <p>A national, web-based database was built to collect cases of neurological symptoms in patients receiving ICI and not attributable to other causes after an adequate workup.</p> <p>We identified 27 patients who developed nirAEs (20 males, median age 69 years). Patients received anti-PD1/PDL1 (78%), anti-CTLA4 (4%), or both (19%). Most common cancers were melanoma (30%) and non-small cell lung cancer (26%). Peripheral nervous system was mostly affected (78%). Median time to onset was 43.5 days and was shorter for peripheral versus central nervous system toxicities (36 versus 144.5 days, p = 0.045). Common manifestations were myositis (33%), inflammatory polyradiculoneuropathies (33%), and myasthenia gravis (19%), alone or in combination, but the spectrum of diagnoses was broad. Most patients received first-line glucocorticoids (85%) or IVIg (15%). Seven patients (26%) needed second-line treatments. At last follow-up, four (15%) patients were deceased (encephalitis, 1; myositis/myasthenia with concomitant myocarditis, 2; acute polyradiculoneuropathy, 1), while seven (26%) had a complete remission, eight (30%) partial improvement, and six (22%) stable/progressing symptoms. ICI treatment was discontinued in most patients (78%).</p> <p>Neurological irAEs are rare but potentially fatal. They primarily affect neuromuscular structures but encompass a broad range of presentations. A prompt recognition is mandatory to timely withheld immunotherapy and administrate glucocorticoids. In corticoresistant or severely affected patients, second-line treatments with IVIg or plasmapheresis may result in additional benefit.</p>

restrictedOct 2021View details →
zenodo12/100

dataset related to article "Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade"

<p>Dataset related to publication at title</p>

restrictedJan 2022View details →
zenodo12/100

DATASET RELATED TO ARTICLE "Besta-Telehealth Task Force. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic"

<p>Data releted on visit access of patients involved&nbsp;in the study described at title</p>

restrictedFeb 2022View details →
geo12/100

Hyperactivation of Necdin, a new biomarker for Cockayne syndrome neurological disease

GEO Series GSE206854. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJun 2022View details →
zenodo8/100

Dataset for the article "Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients"

<p>This is the anonymized dataset for the article entitled &quot;Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer&#39;s disease compared to neurological disease controls: a retrospective study on 276 patients&quot;.</p>

restrictedJan 2023View details →
zenodo8/100

Dataset for the article "Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations"

<p>This is the dataset for the article &quot;Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations&quot;.</p>

restrictedJan 2023View details →
zenodo8/100

data set related to article Lung ultrasound in young children with neurological impairment: A proposed integrative clinical tool for deaeration-detection related to feeding

<p>This record contains raw data related to article Lung ultrasound in young children with neurological impairment: A proposed integrative clinical tool for deaeration-detection related to feeding</p> <p>Per la richiesta di accesso al file contattare la Dr.ssa Simona Fiori all&#39;indirizzo email simona.fiori@fsm.unipi.it</p>

restrictedFeb 2023View details →
zenodo8/100

Pay attention: you can fall! The Mini-BESTest scale and the turning duration of the TUG test provide valid balance measures in neurological patients: a prospective study with falls as the balance criterion

<p>The Excel file contains the database used for the LASSO logistic regression, i.e. the study&#39;s primary analysis (Figure 3 in the main text).</p>

restrictedSep 2023View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.